Jump to navigation

  • 24 hour numbers
  • Urgent Care
    • 617-253-1311
  • Urgent Mental Health Concerns
    • 617-253-2916
  • Violence Prevention & Response
    • 617-253-2300
  • All contact numbers
  • Close

 

MIT Medical logo
24-hour Numbers
Log in to HealthELife

 

Search

MIT Logo
  • Find Patient Services Care, claims, and more
  • Find a Provider By name, specialty, or location
  • Make an Appointment Online or over the phone
  • Learn about Health Plans Choices & coverage
  • Stay Healthy at MIT For the whole community
  • Start
    Here
    Info & resources just for you
    • Information For
    • Information for New Students
    • Information for Parents
    • Information for Undergraduate Students
    • Information for Graduate Students
    • Information for Campus Employees
    • Information for Lexington Employees
    • Information for New Employees
    • Information for Internationals
    • Information for Retirees
    • Information for Affiliates

COVID-19 testing | COVID-19 updates | Covid Pass testing results | Covid Pass testing hours

Covid-19 Updates

Should people with COVID-19 avoid anti-inflammatories?

April 16, 2020 | Kim Schive

April 16: MIT Medical answers your COVID-19 questions. Got a question about COVID-19? Send it to us at CovidQ@mit.edu, and we’ll do our best to provide an answer. 

Is it true that people should avoid anti-inflammatory drugs if infected with COVID-19?

Illustration of a bottle of anti-inflammatory tablets

Unclear. This advice has been erroneously attributed to the World Health Organization. However, it actually began spreading after a March 14 tweet from French Health Minister Olivier Véran, cautioning COVID-19 patients against ibuprofen and encouraging the use of acetaminophen (Tylenol) instead. This warning was, apparently, based on anecdotal reports that some people who had taken ibuprofen — one of a part of a broader class of drugs called “non-steroidal anti-inflammatory drugs” or NSAIDs — experienced a worsening of their symptoms. 

Both the US Food and Drug Administration (FDA) and the European Medicines Agency quickly responded with statements asserting that there is no current scientific evidence for a link between NSAIDs and worsening of COVID 19 symptoms. However, both agencies are continuing to investigate the question. In addition, the FDA statement noted that “all prescription NSAID labels warn that ‘the pharmacological activity of NSAIDs in reducing inflammation, and possibly fever, may diminish the utility of diagnostic signs in detecting infections.’”

Beyond a masking of symptoms, it’s also the case that when sick individuals take any drug to reduce fever, they may be interfering with the body’s natural defenses against infection. At least one study found that symptoms lasted longer when patients took fever-reducing drugs — though it’s important to note that we don’t know if this would be the case in individuals with COVID-19. On the other hand, high fevers can be dangerous, especially for the very young, pregnant women, and individuals with certain underlying medical conditions. Not to mention that fevers make us feel miserable. 

The bottom line is that we don’t yet have enough information to answer this question definitively but recommend healthy skepticism of blanket claims about the use of either type of medication for the treatment of fever associated with COVID-19. Since both NSAIDs and acetaminophen have potential side effects, this is a question to be discussed with your own healthcare provider, who can give you advice about which medication to take or whether you should take medication at all. 

This news story has not been updated since the date shown. Information contained in this story may be outdated. For current information about MIT Medical’s services, please see relevant areas of the MIT Medical website.

MEMBERS OF THE MIT COMMUNITY ONLY:
If you are experiencing symptoms of COVID-19, call MIT Medical’s COVID-19 hotline at 617-253-4865.

COVID-19 FAQ
COVID-19 Vaccine information
Testing for COVID-19 FAQ
Positive tests: Isolation, quarantine, and re-testing FAQ
Managing prescriptions FAQ
Student/Affiliate Extended Insurance Plan FAQ

SHARE THIS

this block intentionally left blank by CSS

Cambridge
MIT Medical
Building E23
25 Carleton Street
Cambridge, MA 02142
 
M-F 8 a.m.-5 p.m.
617-253-4481
617-258-0656 (TTY)
Lexington
MIT Lincoln Laboratory
Annex V
244 Wood Street
Lexington, MA 02421
 
M-F 8 a.m.-5 p.m.
781-981-7080
781-981-6600 (TTY)
Urgent Care
MIT Medical
Building E23
25 Carleton Street
Cambridge, MA 02142
 
M–F 8 a.m. – 8 p.m.
Sat, Sun 10 a.m.– 4 p.m.
617-253-1311
617-258-0656 (TTY)

 

FAST FIND

  • About Us
  • Contact Us
  • Follow Us
  • News & Events
  • HealthELife
  • FAQs
  • Forms & Documents
  • Patient Rights
  • Privacy
  • Accessibility
  • Accreditation
  • Advisory Committees
  • Mission & Vision
  • Jobs

INFORMATION FOR:

  • Information For
  • Information for New Students
  • Information for Parents
  • Information for Undergraduate Students
  • Information for Graduate Students
  • Information for Campus Employees
  • Information for Lexington Employees
  • Information for New Employees
  • Information for Internationals
  • Information for Affiliates
  • Information for Retirees
Follow Us Facebook iconTwitter icon
Massachusetts Institute of Technology
© 2021 MIT Medical All rights reserved